Cell Marque Corporation (CAGE Code 4A9H0) - NSN Parts Catalog
Just NSN Parts, owned and operated by ASAP Semiconductor, supplies various Cell Marque Corporation (CAGE Code 4A9H0) manufacturer parts like 208A-74, 223A-14, 319M-14, 145M95, 108M-96. You can type in the NSN such as 6550015952658, 6550015941769, 6550015952668, 6550016105436, 6550015941934 into our user-friendly search engine to find the exact part you need from Cell Marque Corporation. Each and every part is cross-referenced, and quality assured to ensure our customers only receive premium products from the manufacturer Cell Marque Corporation. We are AS9120B, ISO 9001:2015 certified and FAA AC 0056B accredited.
ASAP is the only independent distributor with a No China Sourcing Policy. As your purchasing partner, we aim to streamline your part procurement process. Fill out a request for quote form today to get started.
CAGE Code: 4A9H0
| Part No | NSN | Item Name | Contract No | QTY | RFQ |
|---|---|---|---|---|---|
| 208A-74 | 6550-01-595-2658 | gh specification | NA | Avl | RFQ |
| 223A-14 | 6550-01-594-1769 | a 1 antitrypsi specification | NA | Avl | RFQ |
| 319M-14 | 6550-01-595-2668 | cytokeratin 19 specification | NA | Avl | RFQ |
| 145M95 | 6550-01-610-5436 | limphoma marker | NA | Avl | RFQ |
| 108M-96 | 6550-01-594-1934 | cd8 specification | NA | Avl | RFQ |
| 336A 74 | 6550-01-595-2723 | synaptophysin specification | NA | Avl | RFQ |
| 247M-94 | 6550-01-595-2634 | ema e29 specification | NA | Avl | RFQ |
| 277M094 | 6550-01-610-5265 | bone marrow marker | NA | Avl | RFQ |
| 313M-15 | 6550-01-600-1311 | cytokeratin cocktai | NA | Avl | RFQ |
| 210A-14 | 6550-01-595-2710 | prolactin specification | NA | Avl | RFQ |
| 246R-15 | 6550-01-595-2633 | e cadherin specification | NA | Avl | RFQ |
| 329M 94 | 6550-01-610-5143 | kidney antibody | NA | Avl | RFQ |
| 352A-74 | 6550-01-600-1331 | napsin a | NA | Avl | RFQ |
| 227M-94 | 6550-01-594-1789 | bcl 6 specification | NA | Avl | RFQ |
| 289A 74 | 6550-01-595-2689 | myeloperoxidas specification | NA | Avl | RFQ |
| 157M 94 | 6550-01-594-1848 | cd57 specification | NA | Avl | RFQ |
| 203A-14 | 6550-01-594-1758 | alpha fetoprot specification | NA | Avl | RFQ |
| 291M-15 | 6550-01-595-2685 | muc2 specification | NA | Avl | RFQ |
| 336R-94 | 6550-01-600-1558 | synaptophysin | NA | Avl | RFQ |
| 229A-14 | 6550-01-594-1800 | cacitonin specification | NA | Avl | RFQ |
| 147M 96 | 6550-01-594-1910 | cd45ro specification | NA | Avl | RFQ |
| 292M-94 | 6550-01-600-1322 | muc5ac | NA | Avl | RFQ |
| 207A-74 | 6550-01-595-2644 | fsh specification | NA | Avl | RFQ |
| 236A-14 | 6550-01-595-2620 | cea polyclonal specification | NA | Avl | RFQ |
| 207A-78 | 6550-01-600-1369 | fsh | NA | Avl | RFQ |
| 282M-94 | 6550-01-595-2681 | melanoma specification | NA | Avl | RFQ |
| 248M-15 | 6550-01-595-2686 | ep cam specification | NA | Avl | RFQ |
| 274M 95 | 6550-01-595-2667 | kappa light ch specification | NA | Avl | RFQ |
| 236M 94 | 6550-01-594-1943 | cea31 specification | NA | Avl | RFQ |
| 209A 14 | 6550-01-595-2675 | lh specification | NA | Avl | RFQ |
| 256A-14 | 6550-01-595-2652 | gastrin specification | NA | Avl | RFQ |
| 265M 15 | 6550-01-595-2663 | hhv 8 specification | NA | Avl | RFQ |
| 348M-94 | 6550-01-595-2754 | wt 1 specification | NA | Avl | RFQ |
| 144M-94 | 6550-01-610-5141 | urothelial bladder | NA | Avl | RFQ |
| 257M-14 | 6550-01-595-2762 | gcdfp 15 specification | NA | Avl | RFQ |
| 202M-95 | 6550-01-600-1556 | actin smooth muscle | NA | Avl | RFQ |
| 161M-16 | 6550-01-594-1921 | cd61 specification | NA | Avl | RFQ |
| 168M-95 | 6550-01-594-1929 | cd68 specification | NA | Avl | RFQ |
| 143M 16 | 6550-01-594-1901 | cd43 specification | NA | Avl | RFQ |
| 215A-74 | 6550-01-600-1364 | helicobacter pylori | NA | Avl | RFQ |
| 131M-96 | 6550-01-594-1887 | cd31 specification | NA | Avl | RFQ |
| 273A 14 | 6550-01-595-2662 | insulin specification | NA | Avl | RFQ |
| 245M 15 | 6550-01-595-2629 | epstein barr v specification | NA | Avl | RFQ |
| 206A-74 | 6550-01-594-1755 | acth specification | NA | Avl | RFQ |
| 323R-16 | 6550-01-595-2707 | progestorone r specification | NA | Avl | RFQ |
| 117R-16 | 6550-01-596-6096 | cd117 c kit specification | NA | Avl | RFQ |
| 338A-74 | 6550-01-595-2729 | tdt specification | NA | Avl | RFQ |
| 453M-94 | 6550-01-600-1332 | p53 | NA | Avl | RFQ |
| 239M 15 | 6550-01-595-2625 | collagen type specification | NA | Avl | RFQ |
| 358M-14 | 6550-01-595-2688 | mum1 specification | NA | Avl | RFQ |
| 262A-18 | 6550-01-600-1566 | granzyme b | NA | Avl | RFQ |
| 235R-14 | 6550-01-600-1385 | cdx 2 | NA | Avl | RFQ |
| 250A 16 | 6550-01-595-2639 | factor viii specification | NA | Avl | RFQ |
| 121R 15 | 6550-01-594-1881 | cd21 specification | NA | Avl | RFQ |
| 231M-14 | 6550-01-594-1811 | calpolin specification | NA | Avl | RFQ |
| 260M-14 | 6550-01-595-2659 | glycophorin a specification | NA | Avl | RFQ |
| 199R 14 | 6550-01-594-1940 | cd99 specification | NA | Avl | RFQ |
| 234A-14 | 6550-01-600-1553 | hcg | NA | Avl | RFQ |
| 213M-15 | 6550-01-595-2619 | cytomegaloviru specification | NA | Avl | RFQ |
| 306M-14 | 6550-01-595-2697 | nse e27 specification | NA | Avl | RFQ |
| 302M-14 | 6550-01-595-2693 | neurofilament specification | NA | Avl | RFQ |
| 204M-16 | 6550-01-594-1765 | alk protein specification | NA | Avl | RFQ |
| 340M-14 | 6550-01-595-2734 | thyroglobulin specification | NA | Avl | RFQ |
| 457M-94 | 6550-01-595-2702 | p57 specification | NA | Avl | RFQ |
| 130M 95 | 6550-01-594-1884 | cd30 specification | NA | Avl | RFQ |
| 145M-94 | 6550-01-594-1908 | cd45 specification | NA | Avl | RFQ |
| 264M 94 | 6550-01-595-2757 | hepatocyte spe specification | NA | Avl | RFQ |
| 232A-74 | 6550-01-594-1818 | calretinin specification | NA | Avl | RFQ |
| 120M 85 | 6550-01-594-1876 | cd20 specification | NA | Avl | RFQ |
| 252M 14 | 6550-01-595-2641 | fascin specification | NA | Avl | RFQ |
| 341M-96 | 6550-01-600-1333 | tracp | NA | Avl | RFQ |
| 241R-15 | 6550-01-595-2630 | cyclin d1 specification | NA | Avl | RFQ |
| 238M-95 | 6550-01-600-1371 | chromogranin a | NA | Avl | RFQ |
| 332A-14 | 6550-01-595-2719 | somatostatin specification | NA | Avl | RFQ |
| 329M-95 | 6550-01-595-2717 | renal cell car specification | NA | Avl | RFQ |
| 156M-84 | 6550-01-594-1916 | cd56 specification | NA | Avl | RFQ |
| 255M-16 | 6550-01-595-2650 | galectin 3 specification | NA | Avl | RFQ |
| 241R-14 | 6550-01-600-1310 | cyclin d1 | NA | Avl | RFQ |
| 134M-15 | 6550-01-594-1895 | cd34 specification | NA | Avl | RFQ |
| 134M-14 | 6550-01-594-1893 | cd34 specification | NA | Avl | RFQ |
| 341M 94 | 6550-01-595-2738 | tracp specification | NA | Avl | RFQ |
| 145M-96 | 6550-01-600-1549 | cd45 lca | NA | Avl | RFQ |
| 320M 14 | 6550-01-595-2766 | cytokeratin 20 specification | NA | Avl | RFQ |
| 283M-16 | 6550-01-595-2682 | mesothelial ce specification | NA | Avl | RFQ |
| 307M-94 | 6550-01-595-2674 | cytokeratin 7 specification | NA | Avl | RFQ |
| 224A-14 | 6550-01-594-1830 | beta catenin specification | NA | Avl | RFQ |
| 211A-14 | 6550-01-595-2747 | tsh specification | NA | Avl | RFQ |
| 236M-98 | 6550-01-600-1376 | cea | NA | Avl | RFQ |
| 138M-16 | 6550-01-594-1865 | cd138 specification | NA | Avl | RFQ |
| 404A-14 | 6550-01-600-1552 | c4d | NA | Avl | RFQ |
| 119M-16 | 6550-01-594-1838 | cd19 specification | NA | Avl | RFQ |
| 334M-84 | 6550-01-610-5144 | prostate cell marke | NA | Avl | RFQ |
| 248M 94 | 6550-01-610-5447 | mesothelioma antibo | NA | Avl | RFQ |
| 281M-85 | 6550-01-600-1316 | mart 1 | NA | Avl | RFQ |
| 321M-15 | 6550-01-595-2704 | plap specification | NA | Avl | RFQ |
